文献速递血栓与止血

2例周期性血小板减少症患者的纵向研究:STAT3与MPL突变

Longitudinal study of 2 patients with cyclic thrombocytopenia, STAT3 and MPL mutations.
PubMed 文献 · Blood Adv · 2023-01-01

该纵向研究对2例血小板计数稳定周期波动且血小板生成素(TPO)呈反向周期的周期性血小板减少症(CTP)患者进行多时间点系统生物学分析,发现血小板特异性基因的周期性表达先于并伴随血小板计数波动,提示周期性血小板生成驱动血小板计数周期。1例患者携带新发种系杂合功能缺失型MPL c.1210G>A突变,2例均携带STAT3致病性体细胞功能获得性变异,且均存在贯穿血小板计数周期的克隆性T细胞群。

要点

  • 血小板特异性基因的周期性表达先于并伴随血小板计数波动,提示周期性血小板生成驱动CTP血小板计数周期。
  • 1例患者携带新发种系杂合功能缺失型MPL c.1210G>A突变,2例均携带STAT3致病性体细胞功能获得性变异。
  • 2例患者均存在贯穿血小板计数周期的克隆性T细胞群,这些突变和克隆性T细胞可能参与致病基线。

核心结论

  • 周期性血小板生成驱动2例CTP患者的血小板计数周期,中性粒细胞和红细胞特异性基因的波动与血小板计数变化相关,符合TPO对造血祖细胞的作用。
  • MPL功能缺失突变、STAT3功能获得性变异及克隆性T细胞可能参与致病基线,使患者内在节律在稳态扰动下呈现夸张的持续性血小板生成振荡。

研究设计与样本

  • 对2例血小板计数稳定周期波动且TPO呈反向周期的CTP患者,在2个周期内多时间点采样并进行系统生物学分析。

主要发现

  • 血液转录组分析显示血小板特异性基因呈周期性表达,先于并伴随血小板计数波动。
  • 中性粒细胞和红细胞特异性基因的波动与血小板计数变化相关。
  • 1例患者携带新发种系杂合功能缺失型MPL c.1210G>A突变,2例均携带STAT3致病性体细胞功能获得性变异。
  • 2例患者均存在贯穿血小板计数周期的克隆性T细胞群。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cyclic thrombocytopenia (CTP) is a rare disease of periodic platelet count oscillations. The pathogenesis of CTP remains elusive. To study the underlying pathophysiology and genetic and cellular associations with CTP, we applied systems biology approaches to 2 patients with stable platelet cycling and reciprocal thrombopoietin (TPO) cycling at multiple time points through 2 cycles. Blood transcriptome analysis revealed cycling of platelet-specific genes, which are in parallel with and precede platelet count oscillation, indicating that cyclical platelet production leads platelet count cycling in both patients. Additionally, neutrophil and erythrocyte-specific genes also showed fluctuations correlating with platelet count changes, consistent with TPO effects on hematopoietic progenitors. Moreover, we found novel genetic associations with CTP. One patient had a novel germline heterozygous loss-of-function (LOF) thrombopoietin receptor (MPL) c.1210G>A mutation, and both had pathogenic somatic gain-of-function (GOF) variants in signal transducer and activator of transcription 3 (STAT3). In addition, both patients had clonal T-cell populations that remained stable throughout platelet count cycles. These mutations and clonal T cells may potentially involve in the pathogenic baseline in these patients, rendering exaggerated persistent thrombopoiesis oscillations of their intrinsic rhythm upon homeostatic perturbations. This work provides new insights into the pathophysiology of CTP and possible therapies.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Zhang H, Chien M, Hou Y, et al. Longitudinal study of 2 patients with cyclic thrombocytopenia, STAT3 and MPL mutations. Blood Adv. 2023. PMID: 35381066. doi:10.1182/bloodadvances.2021006701

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。